04.09.18

Kala Pharmaceuticals to Present at the 2018 ASCRS Annual Meeting and at the Ophthalmology Innovation Summit

Source: Kala Pharmaceuticals

Kala Pharmaceuticals announced that it will be presenting at the Spotlight on dry eye session at the Ophthalmology Innovation Summit at the American Society of Cataract and Refractive Surgery Annual Meeting (OIS@ASCRS) taking place on April 12, 2018. Data from the phase 3 clinical trials conducted with Inveltys (KPI-121 1%), a topical twice-a-day product candidate for the treatment of inflammation and pain following ocular surgery, will also be presented at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting taking place April 13-17, 2018 in Washington, D.C.

Details of the presentations are as follows:

Meeting: OIS@ASCRS
Session title: Spotlight on Dry Eye
Date: Thursday, April 12, 2018
Time: 10:40 - 11:25 AM (presentation from 10:45-10:51 AM ET)
Location: The Renaissance Washington, D.C. Downtown Hotel
Presenter: Mark Iwicki, Chairman and Chief Executive Officer of Kala Pharmaceuticals

Meeting: ASCRS
Title: Safety and Efficacy of Twice Daily Administration of KPI-121 1% for Ocular Inflammation and Pain Following Cataract Surgery
Date: Monday, April 16, 2018
Time: 2:01 - 2:06 PM ET
Location: Walter E. Washington Convention Center, 143B
Presenter: Terry Kim, M.D., Professor of Ophthalmology, Duke University School of Medicine; Chief, Cornea and External Disease Division; Director, Refractive Surgery Service, Duke University Eye Center

Related Content